Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Antioxidant effects of insulin-like growth factor-I (IGF-I) in rats with advanced liver cirrhosis.

García-Fernández M, Castilla-Cortázar I, Díaz-Sanchez M, Navarro I, Puche JE, Castilla A, Casares AD, Clavijo E, González-Barón S.

BMC Gastroenterol. 2005 Mar 3;5:7.

2.

Antifibrogenic effect in vivo of low doses of insulin-like growth factor-I in cirrhotic rats.

Muguerza B, Castilla-Cortázar I, García M, Quiroga J, Santidrián S, Prieto J.

Biochim Biophys Acta. 2001 May 31;1536(2-3):185-95.

3.

Insulin-like growth factor-I restores the reduced somatostatinergic tone controlling growth hormone secretion in cirrhotic rats.

Castilla-Cortázar I, Aliaga-Montilla MA, Salvador J, García M, Delgado G, González-Barón S, Quiroga J, Prieto J.

Liver. 2001 Dec;21(6):405-9.

PMID:
11903885
4.

Liver transduction with a simian virus 40 vector encoding insulin-like growth factor I reduces hepatic damage and the development of liver cirrhosis.

Vera M, Sobrevals L, Zaratiegui M, Martinez L, Palencia B, Rodríguez CM, Prieto J, Fortes P.

Gene Ther. 2007 Feb;14(3):203-10. Epub 2006 Oct 5.

PMID:
17024107
5.

Enhanced actions of insulin-like growth factor-I and interferon-alpha co-administration in experimental cirrhosis.

Tutau F, Rodríguez-Ortigosa C, Puche JE, Juanarena N, Monreal I, García Fernández M, Clavijo E, Castilla A, Castilla-Cortázar I.

Liver Int. 2009 Jan;29(1):37-46. doi: 10.1111/j.1478-3231.2008.01770.x. Epub 2008 Jun 9.

PMID:
18544128
6.

Insulin-like growth factor-I reverts testicular atrophy in rats with advanced cirrhosis.

Castilla-Cortazar I, Garcia M, Quiroga J, Diez N, Diez-Caballero F, Calvo A, Diaz M, Prieto J.

Hepatology. 2000 Mar;31(3):592-600.

PMID:
10706548
7.

Protective effect of IGF-1 on experimental liver cirrhosis-induced common bile duct ligation.

Cantürk NZ, Cantürk Z, Ozden M, Dalçik H, Yardimoglu M, Tülübas F.

Hepatogastroenterology. 2003 Nov-Dec;50(54):2061-6.

PMID:
14696465
8.

Hepatoprotective effects of insulin-like growth factor I in rats with carbon tetrachloride-induced cirrhosis.

Castilla-Cortazar I, Garcia M, Muguerza B, Quiroga J, Perez R, Santidrian S, Prieto J.

Gastroenterology. 1997 Nov;113(5):1682-91.

PMID:
9352873
9.

Hematotesticular barrier is altered from early stages of liver cirrhosis: effect of insulin-like growth factor 1.

Castilla-Cortazar I, Diez N, Garcia-Fernandez M, Puche JE, Diez-Caballero F, Quiroga J, Diaz-Sanchez M, Castilla A, Casares AD, Varela-Nieto I, Prieto J, Gonzalez-Baron S.

World J Gastroenterol. 2004 Sep 1;10(17):2529-34.

10.

Mitochondrial protection by low doses of insulin-like growth factor- I in experimental cirrhosis.

Pérez R, García-Fernández M, Díaz-Sánchez M, Puche JE, Delgado G, Conchillo M, Muntané J, Castilla-Cortázar I.

World J Gastroenterol. 2008 May 7;14(17):2731-9.

11.

Effects of IGF-I treatment on osteopenia in rats with advanced liver cirrhosis.

Cemborain A, Castilla-Cortázar I, García M, Muguerza B, Delgado G, Díaz-Sánchez M, Picardi A.

J Physiol Biochem. 2000 Jun;56(2):91-9.

PMID:
11014614
12.

Effects of insulin-like growth factor I on glucose metabolism in rats with liver cirrhosis.

Petersen KF, Jacob R, West AB, Sherwin RS, Shulman GI.

Am J Physiol. 1997 Dec;273(6 Pt 1):E1189-93.

13.

Hepatoprotection and neuroprotection induced by low doses of IGF-II in aging rats.

Castilla-Cortázar I, García-Fernández M, Delgado G, Puche JE, Sierra I, Barhoum R, González-Barón S.

J Transl Med. 2011 Jul 6;9:103. doi: 10.1186/1479-5876-9-103.

14.

Effects of protein deficiency on liver trace elements and antioxidant activity in carbon tetrachloride-induced liver cirrhosis.

González-Reimers E, López-Lirola A, Olivera RM, Santolaria-Fernández F, Galindo-Martín L, Abreu-González P, Sánchez-Sanchez JJ, Martínez-Riera A.

Biol Trace Elem Res. 2003 Summer;93(1-3):127-40.

PMID:
12835497
15.

Low doses of insulin-like growth factor-I improve nitrogen retention and food efficiency in rats with early cirrhosis.

Picardi A, de Oliveira AC, Muguerza B, Tosar A, Quiroga J, Castilla-Cortázar I, Santidrián S, Prieto J.

J Hepatol. 1997 Jan;26(1):191-202.

PMID:
9148011
16.

Little effects of insulin-like Growth Factor-I on testicular atrophy induced by hypoxia.

Diez-Caballero F, Castilla-Cortázar I, Garcia-Fernandez M, Puche JE, Diaz-Sanchez M, Casares AD, Aliaga-Montilla MA, Rodriguez-Borrajo C, Gonzalez-Barón S.

BMC Urol. 2006 Feb 21;6:4.

17.

Protein deficiency and muscle damage in carbon tetrachloride induced liver cirrhosis.

López-Lirola A, González-Reimers E, Martín Olivera R, Santolaria-Fernández F, Galindo-Martín L, Abreu-González P, González-Hernández T, Valladares-Parrilla F.

Food Chem Toxicol. 2003 Dec;41(12):1789-97.

PMID:
14563404
18.

Altered liver gene expression in CCl4-cirrhotic rats is partially normalized by insulin-like growth factor-I.

Mirpuri E, García-Trevijano ER, Castilla-Cortazar I, Berasain C, Quiroga J, Rodriguez-Ortigosa C, Mato JM, Prieto J, Avila MA.

Int J Biochem Cell Biol. 2002 Mar;34(3):242-52.

PMID:
11849991
19.

Effect of insulin-like growth factor I on in vivo intestinal absorption of D-galactose in cirrhotic rats.

Castilla-Cortázar I, Picardi A, Tosar A, Ainzúa J, Urdaneta E, García M, Pascual M, Quiroga J, Prieto J.

Am J Physiol. 1999 Jan;276(1 Pt 1):G37-42.

20.

Low doses of insulin-like growth factor I improve insulin resistance, lipid metabolism, and oxidative damage in aging rats.

García-Fernández M, Delgado G, Puche JE, González-Barón S, Castilla Cortázar I.

Endocrinology. 2008 May;149(5):2433-42. doi: 10.1210/en.2007-1190. Epub 2008 Jan 10.

PMID:
18187555

Supplemental Content

Support Center